X
Novartis’ sickle cell drug gets Breakthrough Therapy designation
https://pharmaphorum.com/news/novartis-sickle-cell-drug-gets-breakthrough-therapy-designation/
Breakthrough Therapy Designation
Zogenix gains Breakthrough status, but GW Pharma still ahead in Dravet syndrome
The FDA has granted Zogenix a Breakthrough Therapy Designation for its pipeline product, ZX008 for the treatment of seizures associated with Dravet syndrome.
Novartis adds Promacta to breakthrough status roll-call
Drug could get new indication based on NIH research
Rebiotix microbiome drug success against C diff infection
Patients suffering from a recurrent C diff infection have benefited from Rebiotix’s microbiome treatment.
New breakthrough designations for Roche’s Alecensa and Actemra
Alecensa and Roactemra are breakthroughs, says FDA.
Janssen’s depression drug gains second breakthrough status
Drug could help prevent some of the 41,000 suicides every year in US
New Breakthrough status for Darzalex in earlier myeloma treatment
Janssen’s drug looking to gain bigger share in crowded myeloma market
